VanEck Genomics and Healthcare Innovators UCITS ETF
CURE.DE
#3347
ETF rank
โ‚น2.08 B
Marketcap
๐Ÿ‡ช๐Ÿ‡บ EU
Market
โ‚น2,668
Share price
-0.65%
Change (1 day)
38.73%
Change (1 year)

Expense ratio and fees for VanEck Genomics and Healthcare Innovators UCITS ETF (CURE.DE)

Total Expense Ratio

Total Expense Ratio as of September 2026: 0.35%